User profiles for Charles Swanton
Charles SwantonFrancis Crick Institute Verified email at crick.ac.uk Cited by 95912 |
[HTML][HTML] Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
…, J Downward, PA Futreal, C Swanton - New England journal …, 2012 - Mass Medical Soc
Background Intratumor heterogeneity may foster tumor evolution and adaptation and hinder
personalized-medicine strategies that depend on results from single tumor-biopsy samples. …
personalized-medicine strategies that depend on results from single tumor-biopsy samples. …
The causes and consequences of genetic heterogeneity in cancer evolution
Recent studies have revealed extensive genetic diversity both between and within tumours.
This heterogeneity affects key cancer pathways, driving phenotypic variation, and poses a …
This heterogeneity affects key cancer pathways, driving phenotypic variation, and poses a …
[PDF][PDF] Clonal heterogeneity and tumor evolution: past, present, and the future
N McGranahan, C Swanton - Cell, 2017 - cell.com
Intratumor heterogeneity, which fosters tumor evolution, is a key challenge in cancer medicine.
Here, we review data and technologies that have revealed intra-tumor heterogeneity …
Here, we review data and technologies that have revealed intra-tumor heterogeneity …
[HTML][HTML] Tracking the evolution of non–small-cell lung cancer
Background Among patients with non–small-cell lung cancer (NSCLC), data on intratumor
heterogeneity and cancer genome evolution have been limited to small retrospective cohorts. …
heterogeneity and cancer genome evolution have been limited to small retrospective cohorts. …
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
As tumors grow, they acquire mutations, some of which create neoantigens that influence
the response of patients to immune checkpoint inhibitors. We explored the impact of …
the response of patients to immune checkpoint inhibitors. We explored the impact of …
[PDF][PDF] Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer
Combination immune checkpoint blockade has demonstrated promising benefit in lung
cancer, but predictors of response to combination therapy are unknown. Using whole-exome …
cancer, but predictors of response to combination therapy are unknown. Using whole-exome …
Neoantigen-directed immune escape in lung cancer evolution
The interplay between an evolving cancer and a dynamic immune microenvironment remains
unclear. Here we analyse 258 regions from 88 early-stage, untreated non-small-cell lung …
unclear. Here we analyse 258 regions from 88 early-stage, untreated non-small-cell lung …
Chromosomal instability drives metastasis through a cytosolic DNA response
Chromosomal instability is a hallmark of cancer that results from ongoing errors in chromosome
segregation during mitosis. Although chromosomal instability is a major driver of tumour …
segregation during mitosis. Although chromosomal instability is a major driver of tumour …
Resolving genetic heterogeneity in cancer
To a large extent, cancer conforms to evolutionary rules defined by the rates at which clones
mutate, adapt and grow. Next-generation sequencing has provided a snapshot of the …
mutate, adapt and grow. Next-generation sequencing has provided a snapshot of the …
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …